Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MCD vs GSK✓SelectedUSD · GSKMCD vs GSK performance historyLatest closeAs of+0.99%11/16
Stock and ETF performance explorer

MCD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-7.6%
GSK return
+9.7%
Excess return
-17.3%
Maximum drawdown
-31.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.0%-0.1%+1.1%+1.0%
7D-2.4%-1.3%-1.1%-2.0%
30D+13.0%+2.7%+10.3%+12.0%
3M+1.4%+2.7%-1.3%+0.4%
6M+0.8%+3.3%-2.6%-0.3%
YTD-8.4%+6.5%-14.8%-10.4%
All-7.6%+9.7%-17.3%-10.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling